Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1984 | 1 |
1987 | 1 |
1989 | 1 |
1991 | 1 |
2013 | 1 |
2015 | 1 |
2016 | 1 |
2024 | 0 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial.
Lancet. 2013 Apr 6;381(9873):1203-10. doi: 10.1016/S0140-6736(12)61763-2. Epub 2013 Feb 20.
Lancet. 2013.
PMID: 23433739
Clinical Trial.
Hepatic and pancreatic metabolism and biliary excretion of the protease inhibitor camostat mesilate.
Beckh K, Weidenbach H, Weidenbach F, Müller R, Adler G.
Beckh K, et al. Among authors: weidenbach f.
Int J Pancreatol. 1991 Nov-Dec;10(3-4):197-205. doi: 10.1007/BF02924157.
Int J Pancreatol. 1991.
PMID: 1787334
Item in Clipboard
Structure of the canine pancreatic lipase gene.
Mickel FS, Weidenbach F, Swarovsky B, LaForge KS, Scheele GA.
Mickel FS, et al. Among authors: weidenbach f.
J Biol Chem. 1989 Aug 5;264(22):12895-901.
J Biol Chem. 1989.
PMID: 2502543
Free article.
Item in Clipboard
Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial.
Rummel M, Kaiser U, Balser C, Stauch M, Brugger W, Welslau M, Niederle N, Losem C, Boeck HP, Weidmann E, von Gruenhagen U, Mueller L, Sandherr M, Hahn L, Vereshchagina J, Kauff F, Blau W, Hinke A, Barth J; Study Group Indolent Lymphomas.
Rummel M, et al.
Lancet Oncol. 2016 Jan;17(1):57-66. doi: 10.1016/S1470-2045(15)00447-7. Epub 2015 Dec 5.
Lancet Oncol. 2016.
PMID: 26655425
Clinical Trial.
Item in Clipboard
General and selective inhibition of pancreatic enzyme discharge using a proteinase inhibitor (FOY-305).
Adler G, Rausch U, Weidenbach F, Arnold R, Kern HF.
Adler G, et al. Among authors: weidenbach f.
Klin Wochenschr. 1984 May 2;62(9):406-11. doi: 10.1007/BF01742297.
Klin Wochenschr. 1984.
PMID: 6202931
Item in Clipboard
Stimulation of pancreatic secretory process in the rat by low-molecular weight proteinase inhibitor. I. Dose-response study on enzyme content and secretion, cholecystokinin release and pancreatic fine structure.
Rausch U, Adler G, Weidenbach H, Weidenbach F, Rudolff D, Koop I, Kern HF.
Rausch U, et al. Among authors: weidenbach f.
Cell Tissue Res. 1987 Jan;247(1):187-93. doi: 10.1007/BF00216561.
Cell Tissue Res. 1987.
PMID: 2435411
Item in Clipboard
Cite
Cite